SALIVARY CANCER
Clinical trials for SALIVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new SALIVARY CANCER trials appear
Sign up with your email to follow new studies for SALIVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tested the drug pembrolizumab in over 1,600 people with various advanced solid tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink or control the tumors. The trial focused on identifying which patients were most likel…
Matched conditions: SALIVARY CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Prostate cancer drug shows promise against rare salivary tumors
Disease control OngoingThis study tests enzalutamide, a drug already approved for prostate cancer, in 46 people with advanced salivary gland cancer that has androgen receptors. The goal is to see if the drug can shrink tumors by at least 30% in 1 out of 5 patients. Researchers are also tracking how lon…
Matched conditions: SALIVARY CANCER
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 15, 2026 11:53 UTC